Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

BACKGROUND & AIMS: We determined the optimal HCV treatment prioritization strategy for interferon-free (IFN-free) HCV direct-acting antivirals (DAAs) by disease stage and risk status incorporating treatment of people who inject drugs (PWID). METHODS: A dynamic HCV transmission and progression mo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Hepatol
Autors principals: Martin, Natasha K., Vickerman, Peter, Dore, Gregory J., Grebely, Jason, Miners, Alec, Cairns, John, Foster, Graham R., Hutchinson, Sharon J., Goldberg, David J., Martin, Thomas C.S., Ramsay, Mary, Hickman, Matthew
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914770/
https://ncbi.nlm.nih.gov/pubmed/26867489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2016.02.007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars